Results 141 to 150 of about 4,765 (219)

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study. [PDF]

open access: yesBlood Adv
García-Sanz R   +15 more
europepmc   +1 more source

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia. [PDF]

open access: yesBlood Adv
Castillo JJ   +14 more
europepmc   +1 more source

Asymptomatic erythematous plaques on the trunk

open access: yesJAAD Case Reports
Madison Novice, BS   +4 more
doaj   +1 more source

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis. [PDF]

open access: yesBlood Adv
Guijosa A   +6 more
europepmc   +1 more source

Multi-omics analysis reveals a unique epigenetic signature in <i>MYD88</i> wild-type Waldenström macroglobulinemia. [PDF]

open access: yesHaematologica
Chohan K   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy